370 related articles for article (PubMed ID: 28002074)
1. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
Norling LV; Ly L; Dalli J
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
[TBL] [Abstract][Full Text] [Related]
2. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
[TBL] [Abstract][Full Text] [Related]
3. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
4. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
5. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
Barden AE; Mas E; Mori TA
Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
[TBL] [Abstract][Full Text] [Related]
6. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
[TBL] [Abstract][Full Text] [Related]
7. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
8. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
Serhan CN
Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and proresolving lipid mediators.
Serhan CN; Yacoubian S; Yang R
Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
12. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.
Tao X; Lee MS; Donnelly CR; Ji RR
Neurotherapeutics; 2020 Jul; 17(3):886-899. PubMed ID: 32696274
[TBL] [Abstract][Full Text] [Related]
13. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
Chiang N; Serhan CN
Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
[TBL] [Abstract][Full Text] [Related]
14. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
[TBL] [Abstract][Full Text] [Related]
15. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
Li QF; Hao H; Tu WS; Guo N; Zhou XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
[TBL] [Abstract][Full Text] [Related]
16. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
Serhan CN; Chiang N; Dalli J
Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
[TBL] [Abstract][Full Text] [Related]
17. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
18. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
19. The roles of special proresolving mediators in pain relief.
Zhang LY; Jia MR; Sun T
Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
[TBL] [Abstract][Full Text] [Related]
20. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
Kwon Y
Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
